Which of the following inhibits gastric phase of gastric secretion: March 2011
**Question:** Which of the following inhibits gastric phase of gastric secretion: March 2011
**Core Concept:** Gastric secretion is a process by which the stomach produces gastric juice, containing hydrochloric acid, pepsin, and mucus, which are essential for digestion and defense against pathogens. The gastric secretion has two phases: the first phase (gastrin-dependent) and the second phase (gastrin-independent).
**Why the Correct Answer is Right:** The correct answer, Diclofenac, is a nonsteroidal anti-inflammatory drug (NSAID) that primarily inhibits the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. Inhibition of COX enzymes blocks the production of prostaglandins, which regulate gastric secretion and mucus production. By doing so, diclofenac reduces gastric secretion, particularly the second phase (gastrin-independent) secretion.
**Why Each Wrong Option is Incorrect:**
A. Omeprazole (Proton Pump Inhibitor - PPI) inhibits the H+/K+-ATPase enzyme in the gastric parietal cell, thereby reducing gastric acid secretion. Omeprazole does not affect the gastrin-dependent phase but inhibits the gastrin-independent phase.
B. Cimetidine (H2-receptor antagonist) competitively blocks histamine binding to H2 receptors on the gastric parietal cell, decreasing gastric acid secretion. Cimetidine does not affect the gastrin-dependent phase but inhibits the gastrin-independent phase.
C. Mepantoline (anticholinergic drug) inhibits acetylcholine release from parasympathetic neurons, reducing gastric acid secretion. Mepantoline affects both gastrin-dependent and gastrin-independent phases, but it does not specifically inhibit the gastrin-independent phase.
**Clinical Pearl:** Understanding the differences between various classes of medications that affect gastric secretion is crucial for prescription and patient management, as well as to differentiate between different drug mechanisms. This knowledge helps in selecting the appropriate medication for acid-related disorders, ensuring patient safety, and reducing potential side effects.
**Correct Answer Explanation:** Diclofenac (nonsteroidal anti-inflammatory drugs - NSAIDs) specifically inhibits the gastrin-independent phase of gastric secretion by blocking prostaglandin synthesis, thereby reducing gastric secretion. This mechanism is distinct from proton pump inhibitors (PPIs) like omeprazole and H2-receptor antagonists like cimetidine, which primarily affect the gastrin-dependent phase.
**Why Each Wrong Option is Incorrect:**
A. Omeprazole (proton pump inhibitor - PPI) inhibits the H+/K+-ATPase enzyme in the gastric parietal cell, decreasing gastric acid secretion. Omeprazole affects the gastrin-dependent phase, but does not specifically inhibit the gastrin-independent phase.
B. Cimetidine (histamine H2-receptor antagonist) competitively blocks histamine H2 receptors on the gastric parietal cell, decreasing gastric acid secretion. Cimetidine affects